相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Common telomerase reverse transcriptase promoter mutations in hepatocellular carcinomas from different geographical locations
Dilek Cevik et al.
WORLD JOURNAL OF GASTROENTEROLOGY (2015)
Therapeutic vaccines against hepatitis C virus
Jihua Xue et al.
INFECTION GENETICS AND EVOLUTION (2014)
Increased Risk of Serious Non-AIDS-Related Events in HIV-Infected Subjects on Antiretroviral Therapy Associated with a Low CD4/CD8 Ratio
Sergio Serrano-Villar et al.
PLOS ONE (2014)
Low-dose cyclophosphamide administered as daily or single dose enhances the antitumor effects of a therapeutic HPV vaccine
Shiwen Peng et al.
CANCER IMMUNOLOGY IMMUNOTHERAPY (2013)
Challenges in cancer vaccine development for hepatocellular carcinoma
Luigi Buonaguro et al.
JOURNAL OF HEPATOLOGY (2013)
High frequency of telomerase reverse-transcriptase promoter somatic mutations in hepatocellular carcinoma and preneoplastic lesions
Jean Charles Nault et al.
NATURE COMMUNICATIONS (2013)
Regulatory T Cells: Mechanisms of Differentiation and Function
Steven Z. Josefowicz et al.
ANNUAL REVIEW OF IMMUNOLOGY, VOL 30 (2012)
Antitumor effect of new multiple antigen peptide based on HLA-A0201-restricted CTL epitopes of human telomerase reverse transcriptase (hTERT)
Zhong-Li Liao et al.
CANCER SCIENCE (2012)
Local-Regional Treatment of Hepatocellular Carcinoma
Riccardo Lencioni et al.
RADIOLOGY (2012)
Translating Tumor Antigens into Cancer Vaccines
Luigi Buonaguro et al.
CLINICAL AND VACCINE IMMUNOLOGY (2011)
The Global Epidemiology of Hepatocellular Carcinoma: Present and Future
Katherine A. McGlynn et al.
CLINICS IN LIVER DISEASE (2011)
Targeting human telomerase reverse transcriptase with recombinant lentivector is highly effective to stimulate antitumor CD8 T-cell immunity in vivo
Olivier Adotevi et al.
BLOOD (2010)
Current status of GV1001 and other telomerase vaccination strategies in the treatment of cancer
V. E. Shaw et al.
EXPERT REVIEW OF VACCINES (2010)
A Vaccine Targeting Telomerase Enhances Survival of Dogs Affected by B-cell Lymphoma
Daniela Peruzzi et al.
MOLECULAR THERAPY (2010)
Metronomic Chemotherapy Enhances Antitumor Effects of Cancer Vaccine by Depleting Regulatory T Lymphocytes and Inhibiting Tumor Angiogenesis
Chi-An Chen et al.
MOLECULAR THERAPY (2010)
A TLR9 agonist enhances therapeutic effects of telomerase genetic vaccine
Antonella Conforti et al.
VACCINE (2010)
Immunogenicity of a recombinant lentiviral vector carrying human telomerase tumor antigen in HLA-B*0702 transgenic mice
Sylvie Rusakiewicz et al.
VACCINE (2010)
Circulating regulatory T cells (CD4+CD25+FOXP3+) decrease in breast cancer patients after vaccination with a modified MHC class II HER2/neu (AE37) peptide
Jeremy D. Gates et al.
VACCINE (2010)
Epidemiology and prevention of hepatocellular carcinoma
Silvia Franceschi et al.
CANCER LETTERS (2009)
Cyclophosphamide Augments Antitumor Immunity: Studies in an Autochthonous Prostate Cancer Model
Satoshi Wada et al.
CANCER RESEARCH (2009)
A Phase II Study of Adoptive Immunotherapy Using Dendritic Cells Pulsed with Tumor Lysate in Patients with Hepatocellular Carcinoma
Daniel H. Palmer et al.
HEPATOLOGY (2009)
Immunoregulatory T cells in the peripheral blood of melanoma patients treated with melanoma antigen-pulsed mature monocyte-derived dendritic cell vaccination
Noriaki Nakai et al.
JOURNAL OF DERMATOLOGICAL SCIENCE (2009)
Predicting survival after liver transplantation in patients with hepatocellular carcinoma beyond the Milan criteria: a retrospective, exploratory analysis
Vincenzo Mazzaferro et al.
LANCET ONCOLOGY (2009)
Coadministration of Telomerase Genetic Vaccine and a Novel TLR9 Agonist in Nonhuman Primates
Sridhar Dharmapuri et al.
MOLECULAR THERAPY (2009)
Impact of viral selected mutations on T cell mediated immunity in chronically evolving and self limiting acute HCV infection
Silvia Guglietta et al.
VIROLOGY (2009)
Preventive Vaccination with Telomerase Controls Tumor Growth in Genetically Engineered and Carcinogen-Induced Mouse Models of Cancer
Carmela Mennuni et al.
CANCER RESEARCH (2008)
Immunogenicity of the hTERT540-548 peptide in cancer
Lynn Wenandy et al.
CLINICAL CANCER RESEARCH (2008)
Combination of docetaxel and recombinant vaccine enhances T-Cell responses and antitumor activity: Effects of docetaxel on immune enhancement
Charlie T. Garnett et al.
CLINICAL CANCER RESEARCH (2008)
Telomerase as a universal tumor antigen for cancer vaccines
Gregory L. Beatty et al.
EXPERT REVIEW OF VACCINES (2008)
Dose translation from animal to human studies revisited
Shannon Reagan-Shaw et al.
FASEB JOURNAL (2008)
Dendritic cell vaccination induces tumor epitope-specific Th1 immune response in medullary thyroid carcinoma
C. Papewalis et al.
HORMONE AND METABOLIC RESEARCH (2008)
Therapeutic vaccination halts disease progression in BALB-neuT mice:: The amplitude of elicited immune response is predictive of vaccine efficacy
Barbara Cipriani et al.
HUMAN GENE THERAPY (2008)
Liver transplantation for hepatocellular carcinoma: Extension of indications based on molecular markers
Myron Schwartz et al.
JOURNAL OF HEPATOLOGY (2008)
Novel advancements in the management of hepatocellular carcinoma in 2008
Josep M. Llovet et al.
JOURNAL OF HEPATOLOGY (2008)
Vaccination of B-CLL patients with autologous dendritic cells can change the frequency of leukemia antigen-specific CD8+ T cells as well as CD4+CD25+FoxP3+ regulatory T cells toward an antileukemia response
I. Hus et al.
LEUKEMIA (2008)
Sorafenib in advanced hepatocellular carcinoma
Josep M. Llovet et al.
NEW ENGLAND JOURNAL OF MEDICINE (2008)
Differential effects of age on circulating and splenic leukocyte populations in C57BL/6 and BALB/c male mice
Lesya M Pinchuk et al.
Immunity & Ageing (2008)
Novel exosome-targeted CD4+ T cell vaccine counteracting CD4+25+ regulatory T cell-mediated immune suppression and stimulating efficient central memory CD8+ CTL responses
Siguo Hao et al.
JOURNAL OF IMMUNOLOGY (2007)
Metronomic cyclophosphamide regimen selectively depletes CD4+ CD25+ regulatory T cells and restores T and NK effector functions in end stage cancer patients
Francois Ghiringhelli et al.
CANCER IMMUNOLOGY IMMUNOTHERAPY (2007)
Levels of circulating regulatory CD4+CD25+ T cells are decreased in breast cancer patients after vaccination with a HER2/neu peptide (E75) and GM-CSF vaccine
Matthew T. Hueman et al.
BREAST CANCER RESEARCH AND TREATMENT (2006)
The global health burden of infection -associated cancers in the year 2002
Donald Maxwell Parkin
INTERNATIONAL JOURNAL OF CANCER (2006)
A phase I/II trial testing immunization of hepatocellular carcinoma patients with dendritic cells pulsed with four α-fetoprotein peptides
LH Butterfield et al.
CLINICAL CANCER RESEARCH (2006)
Regulatory T cells, tumour immunity and immunotherapy
WP Zou
NATURE REVIEWS IMMUNOLOGY (2006)
Cyclophosphamide decreases the number, percentage and the function of CD25+ CD4+ regulatory T cells, which suppress induction of contact hypersensitivity
Y Ikezawa et al.
JOURNAL OF DERMATOLOGICAL SCIENCE (2005)
Inhibition of CD4+25+ T regulatory cell function implicated in enhanced immune response by low-dose cyclophosphamide
MEC Lutsiak et al.
BLOOD (2005)
Telomerase mRNA-transfected dendritic cells stimulate antigen-specific CD8+ and CD4+ T cell responses in patients with metastatic prostate cancer
Z Su et al.
JOURNAL OF IMMUNOLOGY (2005)
Vaccination of advanced hepatocellular carcinoma patients with tumor lysate-pulsed dendritic cells - A clinical trial
WC Lee et al.
JOURNAL OF IMMUNOTHERAPY (2005)
Phase I trial of intratumoral injection of an adenovirus encoding interleukin-12 for advanced digestive tumors
B Sangro et al.
JOURNAL OF CLINICAL ONCOLOGY (2004)
CD4+CD25+ regulatory T cells suppress tumor immunity but are sensitive to cyclophosphamide which allows immunotherapy of established tumors to be curative
F Ghiringhelli et al.
EUROPEAN JOURNAL OF IMMUNOLOGY (2004)
High resolution analysis of cellular immune responses in resolved and persistent hepatitis C virus infection
GM Lauer et al.
GASTROENTEROLOGY (2004)
Hepatocellular carcinoma: role of hepatitis B and hepatitis C viruses proteins in hepatocarcinogenesis
M Anzola
JOURNAL OF VIRAL HEPATITIS (2004)
Prospective pilot study of recombinant granulocyte-macrophage colony-stimulating factor and interferon-γ in patients with inoperable hepatocellular carcinoma
W Reinisch et al.
JOURNAL OF IMMUNOTHERAPY (2002)
Impaired effector function of hepatitis C virus-specific CD8+ T cells in chronic hepatitis C virus infection
H Wedemeyer et al.
JOURNAL OF IMMUNOLOGY (2002)
Prevalence of regulatory T cells is increased in peripheral blood and tumor microenvironment of patients with pancreas or breast adenocarcinoma
UK Liyanage et al.
JOURNAL OF IMMUNOLOGY (2002)
Identification of immunodominant hepatitis C virus (HCV)-specific cytotoxic T-cell epitopes by stimulation with endogenously synthesized HCV antigens
S Urbani et al.
HEPATOLOGY (2001)
Adoptive immunotherapy to lower postsurgical recurrence rates of hepatocellular carcinoma: a randomised trial
T Takayama et al.
LANCET (2000)
Vigorous peripheral blood cytotoxic T cell response during the acute phase of hepatitis C virus infection
M Cucchiarini et al.
CELLULAR IMMUNOLOGY (2000)
分享论文
